The ICGP’s ‘Practical Guide to Integrated Type 2 Diabetes Care’, launched in 2016, advocates an integrated care pathway with the joint involvement of all levels of care (primary, secondary and tertiary levels), in order to optimise the outcomes in patients with diabetes.
Clinical specials
Antihyperglycaemic Therapy in Type 2 Diabetes – List of agents available in Ireland
Download PDF Table 1.
Options for Hormone Replacement Therapy
Download PDF Updated September 2016 MIMS Ireland Copyright®
Chronic Pain
Download PDF Chronic pain has been defined by the International Association for the Study of Pain (IASP) as “pain without apparent biological value that has persisted beyond the normal tissue healing time (usually taken to be three months)”.
ACR-recommended Rheumatoid Arthritis Disease Activity Measures for use in Clinical Practice
Download PDF -Improvements in the treatment of rheumatoid arthritis (RA) over the last few decades means that disease remission is now a realistic goal for many patients.
Acne vulgaris – Diagnosis and Treatment1
Download PDF Epidemiology Acne is a polymorphic chronic inflammatory skin disease commonly affecting the face, back and chest.
Hidradenitis suppurativa – An under-recognised skin condition in primary care
Download PDF Hidradenitis suppurativa (HS), also known as acne inversa, is a chronic, recurrent, inflammatory skin disease that usually develops after puberty.
ICGP 2016 Guidelines on Type 2 Diabetes – Integrated Care1
Download PDF The ICGP’s new ‘Practical Guide to Integrated Type 2 Diabetes Care’, launched in February 2016, has been developed in recognition of the fact that the optimal management of patients with a chronic disease such type 2 diabetes requires a formal and more structured model of care, and the flexibility to deal with the diverse needs of patients at
Diagnosis and Treatment of Benign Prostatic Hyperplasia
Diagnosis of Benign Prostatic Hyperplasia BPH and complications Benign prostatic hyperplasia (BPH) is a histologic diagnosis characterised by proliferation of prostate cells.
Agents used in the Treatment of Benign Prostatic Hyperplasia
Pharmacological treatment Most patients with BPH do not present with obvious surgical indications; they often have milder LUTS which is initially managed with medication.